Remove Chronic Pain Remove Clinical Trials Remove Decriminalization Remove Policy
article thumbnail

Weekly Legislative Roundup 1/18/19

NORML

House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. Meanwhile, a decriminalization bill was defeated in the Virginia House this week. Click here to email your lawmakers in support of decriminalization. Virgin Islands.

article thumbnail

The Ketamine Clinic Craze: Legalities and Possibilities

Canna Law Blog

Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine. Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ).

Therapy 90
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Can medical cannabis survive adult-use legalization?

The Cannigma

We’re not going to get over the fact that there’s not the same sort of clinical trial and that type of evidence for cannabis and cannabis treatments in the very near future for various reasons. There’s the one drug, one target, cannabis is multiple active ingredients and acts on multiple targets in the body.

article thumbnail

Dentons: Cannabis Group Weekly Alert – August 2019 #3

Cannabis Law Report

The National Institute on Drug Abuse published a grant notice to encourage research on the effects of changing US cannabis laws and policies on public health. Iowa’s Medical Cannabidiol Board formally approved a measure to add chronic pain to the list of conditions that qualify a patient for medical cannabis.

Banking 45
article thumbnail

Meritas Law Firms Worldwide Article: Global Cannabis Industry: The Essential Primer

Cannabis Law Report

As more countries legalize or decriminalize the cultivation, manufacture, sale, and use of cannabis, companies across a variety of industries are looking for opportunities to capitalize on this emerging market. Several bills have been introduced in Congress in 2019 that call for legalizing or decriminalizing the substance.

Law 40
article thumbnail

Urge Kentucky Lawmakers to Support Medical Cannabis Reform Today!

NORML

Presidents Barack Obama and Donald Trump have voiced support for state governments deciding their own policies. The National Center for Biotechnology Information has summarized a group of FDA approved randomized clinical trials, finding evidence for cannabis as medicine. So, in seven years why hasn’t Kentucky moved forward?

Data 187
article thumbnail

Dentons’ Cannabis Group Latest Weekly Update – June 2019 #4

Cannabis Law Report

Although the amendments represent an unprecedented level of support for pro-cannabis policies in the House, a similar level of support in the Republican-controlled Senate is unlikely. The Federal Aviation Administration issued a bulletin clarifying its cannabis and CBD policy for pilots.